3.2(top 10%)
impact factor
1.4K(top 20%)
papers
27.9K(top 10%)
citations
65(top 10%)
h-index
3.3(top 10%)
extended IF
1.6K
all documents
29.4K
doc citations
105(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1The Role of Nitric Oxide on Endothelial FunctionCurrent Vascular Pharmacology2012723
2Ginseng Compounds: An Update on their Molecular Mechanisms and Medical ApplicationsCurrent Vascular Pharmacology2009519
3Apoptosis and Acute Brain Ischemia in Ischemic StrokeCurrent Vascular Pharmacology2017316
4Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel StatementCurrent Vascular Pharmacology2011265
5Macrophage Activation in Atherosclerosis: Pathogenesis and Pharmacology of Plaque RuptureCurrent Vascular Pharmacology2005243
6Glucocorticoids and Vascular ReactivityCurrent Vascular Pharmacology2004242
7Microvascular Complications of Type 2 Diabetes MellitusCurrent Vascular Pharmacology2020235
8Cardiac Oxidative Stress and Inflammatory Cytokines Response after Myocardial InfarctionCurrent Vascular Pharmacology2015220
9The Growing Epidemic of Diabetes MellitusCurrent Vascular Pharmacology2020188
10Role of Oxidative-Nitrosative Stress and Downstream Pathways in Various Forms of Cardiomyopathy and Heart FailureCurrent Vascular Pharmacology2005187
11“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL SubclassesCurrent Vascular Pharmacology2011187
12Structural and Functional Alteration of Blood Vessels Caused by Cigarette Smoking: An Overview of Molecular MechanismsCurrent Vascular Pharmacology2007185
13Inflammation, Sleep, Obesity and Cardiovascular Disease.Current Vascular Pharmacology2007180
14Macrovascular Complications of Type 2 Diabetes MellitusCurrent Vascular Pharmacology2020177
15Potential Role of Natural Compounds as Anti-Angiogenic Agents in CancerCurrent Vascular Pharmacology2017171
16Role of Oxidative Stress in Development of Cardiovascular Complications in Diabetes MellitusCurrent Vascular Pharmacology2006160
17Link between Metabolic Syndrome and Insulin ResistanceCurrent Vascular Pharmacology2016147
18Vascular Endothelial Growth Factor (VEGF) Signaling in Tumour Vascularization: Potential and ChallengesCurrent Vascular Pharmacology2017143
19Endothelial Dysfunction, Obesity and Insulin ResistanceCurrent Vascular Pharmacology2014138
20Structure and Function of Poly(ADP-ribose) Polymerase-1: Role in Oxidative Stress-Related PathologiesCurrent Vascular Pharmacology2005136
21Nucleoside Transporter ProteinsCurrent Vascular Pharmacology2009135
22Angiogenesis-regulating microRNAs and Ischemic StrokeCurrent Vascular Pharmacology2015135
23Endothelin-1-Induced Signaling Pathways in Vascular Smooth Muscle CellsCurrent Vascular Pharmacology2007129
24Angiotensin II, Cell Proliferation and Angiogenesis Regulator: Biologic and Therapeutic Implications in CancerCurrent Vascular Pharmacology2004128
25Hypertension and Endothelial Dysfunction: Therapeutic ApproachCurrent Vascular Pharmacology2012123
26Crucial Role of Interferon-γ and Stimulated Macrophages in Cardiovascular DiseaseCurrent Vascular Pharmacology2006121
27Migraine: Pathophysiology, Pharmacology, Treatment and Future TrendsCurrent Vascular Pharmacology2003119
28Angiotensin II Regulates Vascular and Endothelial Dysfunction: Recent Topics of Angiotensin II Type-1 Receptor Signaling in the VasculatureCurrent Vascular Pharmacology2006118
29Molecular Mechanisms of Renal Blood Flow AutoregulationCurrent Vascular Pharmacology2014117
30Endovascular Therapeutic Embolisation: An Overview of Occluding Agents and their Effects on Embolised TissuesCurrent Vascular Pharmacology2009116
31Endothelial Dysfunction, Impaired Endogenous Platelet Inhibition and Platelet Activation in Diabetes and AtherosclerosisCurrent Vascular Pharmacology2008115
32“European Panel On Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive SummaryCurrent Vascular Pharmacology2011110
33Dyslipidaemia in Rheumatoid Arthritis: The Role of Inflammation, Drugs, Lifestyle and Genetic FactorsCurrent Vascular Pharmacology2010109
34Hydrogen Sulfide as a New Endogenous Gaseous Transmitter in the Cardiovascular SystemCurrent Vascular Pharmacology2006108
35Natural Phenolic Compounds as Cardiovascular Therapeutics: Potential Role of their Antiinflammatory EffectsCurrent Vascular Pharmacology2003106
36Diagnostic Value of Postprandial Triglyceride Testing in Healthy Subjects:A Meta-AnalysisCurrent Vascular Pharmacology2011105
37Role of Oxidative and Nitrosative Stress, Longevity Genes and Poly(ADPribose) Polymerase in Cardiovascular Dysfunction Associated with AgingCurrent Vascular Pharmacology2005104
38Endothelial Endocytic Pathways: Gates for Vascular Drug DeliveryCurrent Vascular Pharmacology2004104
39Vitamin D and Cardiovascular DiseaseCurrent Vascular Pharmacology2009103
40Omega-3 Polyunsaturated Fatty Acids: Their Potential Role in Blood Pressure Prevention and ManagementCurrent Vascular Pharmacology2009101
41Endothelial dysfunction in sepsisCurrent Vascular Pharmacology201392
42The Rationale for Comparative Studies of Accelerated Atherosclerosis in Rheumatic DiseasesCurrent Vascular Pharmacology201090
43Diabetes Mellitus and Vascular Endothelial Dysfunction: Current PerspectivesCurrent Vascular Pharmacology201288
44Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?Current Vascular Pharmacology201887
45Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical ApplicationsCurrent Vascular Pharmacology201785
46Omentin: Linking Metabolic Syndrome and Cardiovascular DiseaseCurrent Vascular Pharmacology201482
47Micronized Purified Flavonoid Fraction (MPFF)*: A Review of its Pharmacological Effects, Therapeutic Efficacy and Benefits in the Management of Chronic Venous InsufficiencyCurrent Vascular Pharmacology200580
48Oxidative-Nitrosative Stress In HypertensionCurrent Vascular Pharmacology200580
49Endothelin-1 and Angiogenesis in CancerCurrent Vascular Pharmacology200579
50Sympathetic Overactivity in Hypertension and Cardiovascular DiseaseCurrent Vascular Pharmacology201479